Suppr超能文献

抗抑郁药对大鼠脑皮质5-羟色胺(1A)受体的下调作用

Cortical 5-HT(1A) receptor downregulation by antidepressants in rat brain.

作者信息

Srinivas B N, Subhash M N, Vinod K Y

机构信息

Department of Neurochemistry, National Institute of Mental Health and Neurosciences, P.B. No. 2900, Bangalore 560 029, India.

出版信息

Neurochem Int. 2001 Jun;38(7):573-9. doi: 10.1016/s0197-0186(00)00123-6.

Abstract

Total 5-HT binding sites and 5-HT(1A) receptor density was measured in brain regions of rats treated with imipramine (5 mg/kg body wt), desipramine (10 mg/kg body wt) and clomipramine (10 mg/kg body wt), for 40 days, using [3H]5-HT and [3H]8-OH-DPAT, respectively. It was observed that chronic exposure to tricyclic antidepressants (TCAs) results in significant downregulation of total [3H]5-HT binding sites in cortex (42-76%) and hippocampus (35-67%). The 5-HT(1A) receptor density was, however, decreased significantly (32-60%) only in cortex with all the three drugs. Interestingly, in hippocampus imipramine treatment increased the 5-HT(1A) receptor density (14%). The affinity of [3H]8-OH-DPAT was increased only with imipramine treatment both in cortex and hippocampus. The affinity of [3H]5-HT to 5-HT binding sites in cortex was increased with imipramine treatment and decreased with desipramine and clomipramine treatment. 5-HT sensitive adenylyl cyclase (AC) activity was significantly increased in cortex with imipramine (72%) and clomipramine (17%) treatment, whereas in hippocampus only imipramine treatment significantly increased AC activity (50%). In conclusion, chronic treatment with TCAs results in downregulation of cortical 5-HT(1A) receptors along with concomitant increase in 5-HT stimulated AC activity suggesting the involvement of cortical 5-HT(1A) receptors in the mechanism of action of TCAs.

摘要

分别使用[3H]5-HT和[3H]8-OH-DPAT,对接受丙咪嗪(5毫克/千克体重)、地昔帕明(10毫克/千克体重)和氯米帕明(10毫克/千克体重)治疗40天的大鼠脑区进行5-羟色胺(5-HT)结合位点总数及5-HT(1A)受体密度的测定。结果发现,长期接触三环类抗抑郁药(TCA)会导致皮质(42%-76%)和海马体(35%-67%)中[3H]5-HT结合位点总数显著下调。然而,仅在使用所有这三种药物治疗的皮质中,5-HT(1A)受体密度显著降低(32%-60%)。有趣的是,在海马体中,丙咪嗪治疗可使5-HT(1A)受体密度增加(14%)。仅丙咪嗪治疗可使皮质和海马体中[3H]8-OH-DPAT的亲和力增加。丙咪嗪治疗可使皮质中[3H]5-HT与5-HT结合位点的亲和力增加,而地昔帕明和氯米帕明治疗则使其降低。丙咪嗪(72%)和氯米帕明(17%)治疗可使皮质中5-HT敏感腺苷酸环化酶(AC)活性显著增加,而在海马体中,仅丙咪嗪治疗可使AC活性显著增加(50%)。总之,TCA的长期治疗导致皮质5-HT(1A)受体下调,同时5-HT刺激的AC活性增加,这表明皮质5-HT(1A)受体参与了TCA的作用机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验